Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer —results of an exploratory case–control study

ConclusionsWe demonstrated a similar efficacy of LDMC compared to CCT in the treatment of MBC. Thus, LDMC may be a valuable treatment option in selected MBC patients.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research